Volumetric Modulated Arc Therapy (VMAT) for Delivery of Prostate Radiotherapy: Reduction in Treatment Time and Monitor Unit Requirements Compared to Intensity Modulated Radiotherapy
David A. Palma(Western University), Karl F. Otto(BC Cancer Agency), James Morris(BC Cancer Agency), Sandy Nakano(BC Cancer Agency), Richard Shaffer(Bupa Cromwell Hospital), Michael McKenzie(Provincial Health Services Authority), Vitali Moiseenko(BC Cancer Agency), K. James(BC Cancer Agency), E. Vollans(BC Cancer Agency)
International Journal of Radiation Oncology*Biology*Physics
August 21, 2008
Cited by 17
Related Papers
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
|The Lancet Oncology|2016|1.1k
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
|International Journal of Radiation Oncology*Biology*Physics|2016|736